Chairwoman Maloney's Opening Statement: Unsustainable Drug Prices (Part III)

Chairwoman Maloney's Opening Statement: Unsustainable Drug Prices (Part III)

Oversight Committee
Oversight Committee
9 Video Views·May 18, 2021

Committee on Oversight and Reform Chairwoman Carolyn B. Maloney’s opening statement, as prepared for delivery, during today’s full committee hearing examining the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.